Animal models for studying dengue pathogenesis and therapy
•Good in vivo models of dengue disease are needed to study pathogenesis and test new antiviral therapies.•Experimental human infection is the most realistic model, but cannot include vascular leak and shock seen in severe dengue.•Macaques generally develop low viremia and few signs of illness, but m...
Gespeichert in:
Veröffentlicht in: | Antiviral research 2015-11, Vol.123, p.5-14 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 14 |
---|---|
container_issue | |
container_start_page | 5 |
container_title | Antiviral research |
container_volume | 123 |
creator | Chan, Kitti Wing Ki Watanabe, Satoru Kavishna, Ranmali Alonso, Sylvie Vasudevan, Subhash G. |
description | •Good in vivo models of dengue disease are needed to study pathogenesis and test new antiviral therapies.•Experimental human infection is the most realistic model, but cannot include vascular leak and shock seen in severe dengue.•Macaques generally develop low viremia and few signs of illness, but marmosets show more features of human disease.•Humanized mice permit the study of humoral responses to infection, but have not yet reproduced severe dengue.•Mice lacking a Type I interferon response are currently the best small animal model for testing new drugs against dengue.
Development of a suitable animal model for dengue virus disease is critical for understanding pathogenesis and for preclinical testing of antiviral drugs and vaccines. Many laboratory animal models of dengue virus infection have been investigated, but the challenges of recapitulating the complete disease still remain. In this review, we provide a comprehensive coverage of existing models, from man to mouse, with a specific focus on recent advances in mouse models for addressing the mechanistic aspects of severe dengue in humans. This article forms part of a symposium in Antiviral Research on flavivirus drug discovery. |
doi_str_mv | 10.1016/j.antiviral.2015.08.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1732309948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166354215001990</els_id><sourcerecordid>1732309948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-560c9f7b0518c55702acc6db4043d4d2dd510b23ff07b521a63cd59d52c806de3</originalsourceid><addsrcrecordid>eNqFkD1PwzAURS0EglL4C5CRJeHZju2Erar4kiqxwGw59kvrKk2KnVTqvydVCyvTW869V-8Qck8ho0Dl4zozbe93PpgmY0BFBkUGlJ-RCS0US0so5TmZjKRMucjZFbmOcQ0AUpXFJblikkOuIJ-Qp1nrN6ZJNp3DJiZ1F5LYD27v22XisF0OmGxNv-qW2GL0MTGtS_oVBrPd35CL2jQRb093Sr5enj_nb-ni4_V9Pluklivap0KCLWtVgaCFFUIBM9ZKV-WQc5c75pygUDFe16AqwaiR3DpROsFsAdIhn5KHY-82dN8Dxl5vfLTYNKbFboiaKs44lGVejKg6ojZ0MQas9TaM74W9pqAP4vRa_4nTB3EaCj2KG5N3p5Gh2qD7y_2aGoHZERg14c5j0NF6bC06H9D22nX-35Efx1aDHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1732309948</pqid></control><display><type>article</type><title>Animal models for studying dengue pathogenesis and therapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chan, Kitti Wing Ki ; Watanabe, Satoru ; Kavishna, Ranmali ; Alonso, Sylvie ; Vasudevan, Subhash G.</creator><creatorcontrib>Chan, Kitti Wing Ki ; Watanabe, Satoru ; Kavishna, Ranmali ; Alonso, Sylvie ; Vasudevan, Subhash G.</creatorcontrib><description>•Good in vivo models of dengue disease are needed to study pathogenesis and test new antiviral therapies.•Experimental human infection is the most realistic model, but cannot include vascular leak and shock seen in severe dengue.•Macaques generally develop low viremia and few signs of illness, but marmosets show more features of human disease.•Humanized mice permit the study of humoral responses to infection, but have not yet reproduced severe dengue.•Mice lacking a Type I interferon response are currently the best small animal model for testing new drugs against dengue.
Development of a suitable animal model for dengue virus disease is critical for understanding pathogenesis and for preclinical testing of antiviral drugs and vaccines. Many laboratory animal models of dengue virus infection have been investigated, but the challenges of recapitulating the complete disease still remain. In this review, we provide a comprehensive coverage of existing models, from man to mouse, with a specific focus on recent advances in mouse models for addressing the mechanistic aspects of severe dengue in humans. This article forms part of a symposium in Antiviral Research on flavivirus drug discovery.</description><identifier>ISSN: 0166-3542</identifier><identifier>EISSN: 1872-9096</identifier><identifier>DOI: 10.1016/j.antiviral.2015.08.013</identifier><identifier>PMID: 26304704</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>AG129 mice ; Animal models ; Animals ; Antiviral therapy ; Dengue ; Dengue - drug therapy ; Dengue - virology ; Dengue hemorrhagic fever ; Dengue Virus - pathogenicity ; Disease Models, Animal ; Drug Evaluation, Preclinical - methods</subject><ispartof>Antiviral research, 2015-11, Vol.123, p.5-14</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-560c9f7b0518c55702acc6db4043d4d2dd510b23ff07b521a63cd59d52c806de3</citedby><cites>FETCH-LOGICAL-c371t-560c9f7b0518c55702acc6db4043d4d2dd510b23ff07b521a63cd59d52c806de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.antiviral.2015.08.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26304704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Kitti Wing Ki</creatorcontrib><creatorcontrib>Watanabe, Satoru</creatorcontrib><creatorcontrib>Kavishna, Ranmali</creatorcontrib><creatorcontrib>Alonso, Sylvie</creatorcontrib><creatorcontrib>Vasudevan, Subhash G.</creatorcontrib><title>Animal models for studying dengue pathogenesis and therapy</title><title>Antiviral research</title><addtitle>Antiviral Res</addtitle><description>•Good in vivo models of dengue disease are needed to study pathogenesis and test new antiviral therapies.•Experimental human infection is the most realistic model, but cannot include vascular leak and shock seen in severe dengue.•Macaques generally develop low viremia and few signs of illness, but marmosets show more features of human disease.•Humanized mice permit the study of humoral responses to infection, but have not yet reproduced severe dengue.•Mice lacking a Type I interferon response are currently the best small animal model for testing new drugs against dengue.
Development of a suitable animal model for dengue virus disease is critical for understanding pathogenesis and for preclinical testing of antiviral drugs and vaccines. Many laboratory animal models of dengue virus infection have been investigated, but the challenges of recapitulating the complete disease still remain. In this review, we provide a comprehensive coverage of existing models, from man to mouse, with a specific focus on recent advances in mouse models for addressing the mechanistic aspects of severe dengue in humans. This article forms part of a symposium in Antiviral Research on flavivirus drug discovery.</description><subject>AG129 mice</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antiviral therapy</subject><subject>Dengue</subject><subject>Dengue - drug therapy</subject><subject>Dengue - virology</subject><subject>Dengue hemorrhagic fever</subject><subject>Dengue Virus - pathogenicity</subject><subject>Disease Models, Animal</subject><subject>Drug Evaluation, Preclinical - methods</subject><issn>0166-3542</issn><issn>1872-9096</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAURS0EglL4C5CRJeHZju2Erar4kiqxwGw59kvrKk2KnVTqvydVCyvTW869V-8Qck8ho0Dl4zozbe93PpgmY0BFBkUGlJ-RCS0US0so5TmZjKRMucjZFbmOcQ0AUpXFJblikkOuIJ-Qp1nrN6ZJNp3DJiZ1F5LYD27v22XisF0OmGxNv-qW2GL0MTGtS_oVBrPd35CL2jQRb093Sr5enj_nb-ni4_V9Pluklivap0KCLWtVgaCFFUIBM9ZKV-WQc5c75pygUDFe16AqwaiR3DpROsFsAdIhn5KHY-82dN8Dxl5vfLTYNKbFboiaKs44lGVejKg6ojZ0MQas9TaM74W9pqAP4vRa_4nTB3EaCj2KG5N3p5Gh2qD7y_2aGoHZERg14c5j0NF6bC06H9D22nX-35Efx1aDHw</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Chan, Kitti Wing Ki</creator><creator>Watanabe, Satoru</creator><creator>Kavishna, Ranmali</creator><creator>Alonso, Sylvie</creator><creator>Vasudevan, Subhash G.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151101</creationdate><title>Animal models for studying dengue pathogenesis and therapy</title><author>Chan, Kitti Wing Ki ; Watanabe, Satoru ; Kavishna, Ranmali ; Alonso, Sylvie ; Vasudevan, Subhash G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-560c9f7b0518c55702acc6db4043d4d2dd510b23ff07b521a63cd59d52c806de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>AG129 mice</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antiviral therapy</topic><topic>Dengue</topic><topic>Dengue - drug therapy</topic><topic>Dengue - virology</topic><topic>Dengue hemorrhagic fever</topic><topic>Dengue Virus - pathogenicity</topic><topic>Disease Models, Animal</topic><topic>Drug Evaluation, Preclinical - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Kitti Wing Ki</creatorcontrib><creatorcontrib>Watanabe, Satoru</creatorcontrib><creatorcontrib>Kavishna, Ranmali</creatorcontrib><creatorcontrib>Alonso, Sylvie</creatorcontrib><creatorcontrib>Vasudevan, Subhash G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Antiviral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Kitti Wing Ki</au><au>Watanabe, Satoru</au><au>Kavishna, Ranmali</au><au>Alonso, Sylvie</au><au>Vasudevan, Subhash G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Animal models for studying dengue pathogenesis and therapy</atitle><jtitle>Antiviral research</jtitle><addtitle>Antiviral Res</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>123</volume><spage>5</spage><epage>14</epage><pages>5-14</pages><issn>0166-3542</issn><eissn>1872-9096</eissn><abstract>•Good in vivo models of dengue disease are needed to study pathogenesis and test new antiviral therapies.•Experimental human infection is the most realistic model, but cannot include vascular leak and shock seen in severe dengue.•Macaques generally develop low viremia and few signs of illness, but marmosets show more features of human disease.•Humanized mice permit the study of humoral responses to infection, but have not yet reproduced severe dengue.•Mice lacking a Type I interferon response are currently the best small animal model for testing new drugs against dengue.
Development of a suitable animal model for dengue virus disease is critical for understanding pathogenesis and for preclinical testing of antiviral drugs and vaccines. Many laboratory animal models of dengue virus infection have been investigated, but the challenges of recapitulating the complete disease still remain. In this review, we provide a comprehensive coverage of existing models, from man to mouse, with a specific focus on recent advances in mouse models for addressing the mechanistic aspects of severe dengue in humans. This article forms part of a symposium in Antiviral Research on flavivirus drug discovery.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26304704</pmid><doi>10.1016/j.antiviral.2015.08.013</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0166-3542 |
ispartof | Antiviral research, 2015-11, Vol.123, p.5-14 |
issn | 0166-3542 1872-9096 |
language | eng |
recordid | cdi_proquest_miscellaneous_1732309948 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | AG129 mice Animal models Animals Antiviral therapy Dengue Dengue - drug therapy Dengue - virology Dengue hemorrhagic fever Dengue Virus - pathogenicity Disease Models, Animal Drug Evaluation, Preclinical - methods |
title | Animal models for studying dengue pathogenesis and therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A56%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Animal%20models%20for%20studying%20dengue%20pathogenesis%20and%20therapy&rft.jtitle=Antiviral%20research&rft.au=Chan,%20Kitti%20Wing%20Ki&rft.date=2015-11-01&rft.volume=123&rft.spage=5&rft.epage=14&rft.pages=5-14&rft.issn=0166-3542&rft.eissn=1872-9096&rft_id=info:doi/10.1016/j.antiviral.2015.08.013&rft_dat=%3Cproquest_cross%3E1732309948%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1732309948&rft_id=info:pmid/26304704&rft_els_id=S0166354215001990&rfr_iscdi=true |